Abstract
Aldehydes are ubiquitous pollutants with well-indicated but ill-defined cardiovascular toxicity. To investigate the direct toxic effects of environmental aldehyde exposure on the myocardium, 8-wk-old male ICR (Institute of Cancer Research) strain mice were gavage fed trans-2-hexenal (0.1, 1, 10, or 50 mg/kg/wk) or corn oil (vehicle) for 4 wk, during which cardiac function, myocardial morphology, cardiomyocyte apoptosis, and the cytochrome c-mediated caspase activation apoptotic pathway were determined. Quantification by enzyme-linke immunosorbent assay (ELISA) revealed that aldehyde-protein adducts increase in mouse hearts following hexenal treatment, whereas echocardiographic analysis displayed a significant impairment of basal left-ventricular contractile function. Both histological analysis and TUNEL (terminal deoxynucleotidyl transferase-mediated nick-end labeling) staining indicated condensed nuclei and a significant increase in cardiomyocyte apoptosis in these mice, but immunohistochemistry-based confocal microscope revealed no marked myofibril disarray. Release of cytochrome c from mitochondria into the cytosol, concomitant with activation of caspase-3 and-9, was also found in hexenal-treated groups. In addition, isolated cardiac mitochondria formed hexenal-protein adducts when treated with hexenal, providing indirect evidence that the cardiac mitochondrion is one of primary subcellular targets of aldehyde toxins. These findings suggest that trans-2-hexenal exposure results in direct cardiac toxicity through, at least in part, induction of mitochondrial cytochrome c release-mediated apoptosis in cardiomyocytes, indicating that the cardiac mitochondrion is one of principal subcellular targets of aldehyde toxins.
Similar content being viewed by others
References
Committee on Aldehydes. (1981). Formaldehyde and Other Aldehydes. Board on Toxicology and Environmental Health Hazards, Assembly of Life Sciences, National Research Council, National Academy Press, Washington, DC, pp. 234–241.
Environmental Protection Agency. (1997). National Air Quality Standards for Particulate Matter. Environmental Protection Agency, Washington, DC.
Levine, R. J., Andjelkovich, D. A., and Shaw, L. K. (1984). The mortality of Ontario undertakers and a review of formaldehyde-related mortality studies. J. Occup. Med. 26:740–746.
Matanoski, G. M. and Schwartz, L. (1987). Mortality of workers in styrene-butadiene polymer production. J. Occup. Med. 29:675–680.
Seaton, A., MacNee, W., Donaldson, K., and Godden, D. (1995). Particulate air pollution and acute health effects. Lancet 345:176–178.
Stewart, P. A., Schairer, C., and Blair, A. (1990). Comparison of jobs, exposures, and mortality risks for shortterm and long-term workers. J. Occup. Med. 32:703–708.
Walrath, J. and Fraumeni, J. F. Jr. (1984). Cancer and other causes of death among embalmers. Cancer Res. 44:4638–4641.
Magari, S. R., Hauser, R., Schwartz, J., Williams, P. L., Smith, T. J., and Christiani, D. C. (2001). Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 104: 989–991.
Peters, A., Dockery, D. W., Muller, J. E., and Mittleman, M. A. (2001). Increased particulate air pollution and the triggering of myocardial infarction. Circulation 103:2810–2815.
Elsässer, A., Suzuki, K., Lorenz-Meyer, S., Bode, C., and Schaper, J. (2001). The role of apoptosis in myocardial ischemia: a critical appraisa. Basic Res. Cardiol. 96:219–226.
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Chen, W., Nitahara, J. A., et al. (1997). Apoptosis in the failure human heart. N. Engl. J. Med. 336:1131–1141.
Haynes, R. L., Brune, B., and Townsend, A. J. (2001). Apoptosis in RAW 264.7 cells exposed to 4-hydroxy-2-nonenal: dependence on cytochrome c release but not p53 accumulation. Free Radic. Biol. Med. 30:884–894.
Herbst, U., Toborek, M., Kaiser, S., Mattson, M. P., and Hennig, B. (1994). 4-hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J. Cell Physiol. 181:295–303.
Ruef, J., Moser, M., Bode, C., Kubler, W., and Runge, M. S. (2001). 4-hydroxynonenal induces apoptosis, NF-κB-activation and formation of 8-isoproatane in vascular smooth muscle cells. Basic Res. Cardiol. 96:143–150.
Zhang, W., He, Q., Chan, L. L., Zhou, F., El Naghy, M., Thompson, E. B., et al. (2001). Involvement of caspases in 4-hydroxy-alkenal-induced apoptosis in human leukemic cells. Free Radic. Biol. Med. 30:699–706.
Ji, C., Amarnath, V., Pietenpol, J.A., and Marnett, L.J. (2001). 4-Hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome crelease. Chem. Res. Toxicol. 14:1090–1096.
Liu, W., Kato, M., Akhand, A.A., Hayakawa, A., Suzuki, H., Miyata, T., et al. (2000). 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell. Sci. 113:635–642.
Esterbauer, H. (1993). Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57:S779-S786.
Yazdanpanah, M., Luo, X.P., Lau, R., Greenberg, M., Fisher, L.J., and Lehotay, D.C. (1997). Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic. Biol. Med. 23:870–878.
Humphris, K.M., Yoo, Y., and Szweda, L.I. (1998). Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 37:552–557.
Kowaltowski, A.J. and Vercesi, A.E. (1999). Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26:463–471.
Green, D.R. and Reed, J.C. (1998). Mitochondria and apoptosis. Science 281:1309–1312.
Grutter, M.G. (2000). Caspases: key players in programed cell death. Curr. Opin. Struc. Biol. 10:649–655.
Zielinski, T.L., Smith, S.A., Pestka, J.J., Gray, J.I., and Smith, D.M. (2001). ELISA to quantify hexanal-protein adducts in a meat model system. J. Agric. Food Chem. 49: 3017–3023.
Smith, S.A., Pestka, J.J., Gray, J.I., and Smith, D.M. (1999). Production and specificity of polyclonal antibodies to hexanal-lysine adducts. J. Agric. Food Chem. 47: 1389–1395.
Prabhu, S.D., Chandrasekar, B., Murray, D.R., and Freeman, G.L. (1998). β-Adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 98:149–156.
Ping, P., Takano, H., Zhang, J., Tang, X.L., Qiu, Y., Li, R.C., et al. (1999). Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ. Res. 84:587–604.
Baines, C.P., Zhang, J., Wang, G.W., Zheng, Y.T., Xiu, J.X., Cardwell, E.M., et al. (2002). Mitochondrial PKCε and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ. Res. 90:390–397.
Ghilarducci, D.P. and Tjeerdema, R.S. (1995). Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144: 95–144.
Laplanche, A., Clavel-Chapelon, F., Contassot, J.C., and Lanouiere, C. (1992). Exposure to vinvyl chloride monomer: results of a cohort study after a seven year follow up. The French VCM Group. Br. J. Ind. Med. 49:134–137.
Feron, V.J., Til, H.P., de Vrijer, F., Woutersen, R.A., Cassee, F.R., and van Bladeren, P.J. (1991). Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259:363–385.
Eder, E. and Schuler, D. (2000). An approach to cancer risk assessment for the food constituent 2-hexenal on the basis of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo. Arch. Toxicol. 74:642–648.
Eder, E. and Budiawan, S.D. (1999). Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. IARC Scientific Publications 150:219–232.
Majno, G. and Joris, I. (1995). Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 146: 3–15.
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F.D., et al. (1999). Apoptosis in heart failure: release of cytochromec from mitochondria and activation of caspases-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. USA 96:8144–8149.
Arola, O.J., Saraste, A., Pulkki, K., Kallajoki, M., Parvinen, M., and Voipio-Pulkki, L.M. (2000). Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 60:1789–1792.
Sharma, K., Wang, R.X., Zhang, L.Y., Yin, D.L., Luo, X.Y., Solomon, J.C., et al. (2000). Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 88:333–347.
Wallach, D., Varfolomeev E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V., and Boldin, M.P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331–367.
Condorelli, G., Roncarati, R., Ross, J., Jr., Pisani, A., Stassi, G., Todaro, M., et al. (2001). Heart-targeted overexpression of caspase-3 in mice increases infarct size and depresses cardiac function. Proc. Natl. Acad. Sci. USA 98: 9977–9982.
Laugwitz, K.L., Moretti, A., Weig, H.J., Gillitzer, A., Pinkernell, K., Ott, T., et al. (2001). Blocking caspase-activated apoptosis improves contractility in failure myocardium. Hum. Gene Ther. 12:2051–2063.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peipei Ping and Christopher P. Baines contributed equally to this study.
Rights and permissions
About this article
Cite this article
Ping, P., Baines, C.P., Gu, Y. et al. Cardiac toxic effects of trans-2-hexenal are mediated by induction of cardiomyocyte apoptotic pathways. Cardiovasc Toxicol 3, 341–351 (2003). https://doi.org/10.1385/CT:3:4:341
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CT:3:4:341